Author

Duygu Uçku

Koç UniversityORCID 0000-0002-4686-8054Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adam P. CribbsiD· 1 shared Buse CevatemreiD· 1 shared Ceyda AçılaniD· 1 shared Ezgi Yağmur KalaiD· 1 shared Feridun AksuiD· 1 shared James E. DunfordiD· 1 shared Martin PhilpottiD· 1 shared Nareg Pinarbasi DegirmenciiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam P. CribbsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Chemical screens identify HDAC6 as an epigenetic vulnerability in acquired Temozolomide-resistant models of glioblastoma

Feridun Aksu, Buse Cevatemre, Nareg Pinarbasi Degirmenci, Ezgi Yağmur Kala, Duygu Uçku, Martin Philpott, Adam P. Cribbs, James E. Dunford, Udo C. T. Oppermann, Ceyda Açılan, Tugba Bagci Onder

The paper identifies HDAC6 as an epigenetic vulnerability in TMZ-resistant glioblastoma models and shows HDAC6 inhibitors can restore TMZ sensitivity.

bioRxiv · May 11, 2026 · PreprintCancer Biology